Info

Thyroid Factor

The Natural Thyroid Diet

Get Instant Access

Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type 2 cryoglobulinemia. N Engl J Med 1992;327:1490-1495. 35.

Cacoub P, Fabiani FL, Musset L, et al. Mixed cryoglobulinemia and hepatitis C virus. Am J Med 1994;96:124-132.

Haddad J, Deny P, Munz-Gotheil C, et al. Lymphocytic sialadenitis of Sjogren's syndrome associated 36. with chronic hepatitis C virus liver disease. Lancet 1992;339:321-323.

Mariette X, Zerbib M, Jaccard A, Schenmetzler C, 37.

Danon F, Clauvel JP. Hepatitis C virus and Sjogren's syndrome. Arthritis rheum 1993;36:280-281. Siegel LB, Cohn L, Nashel D. Rheumatic manifestations of hepatitis C infection. Sem Arthritis Rheum 38. 1993;23:149-154.

Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: A mimic of rheumatoid arthritis. J Rheumatol 39. 1996;23:979-983.

Ferri C, Monti M, La Civita L, et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinemia. Eur J Clin Invest 1994;24:781-784. 40.

Pozzato G, Mazzaro C, Crovatto M, et al. Low-grade malignant lymphoma, hepatitis C virus infection, and mixed cryoglobulinemia. Blood 1994;84:3047-3053.

Sikuler E, Schnaider A, Zilberman D, Hilzenrat N, 41. Shemer-Avni Y, Neumann L, Buskila D. Hepatitis C virus infection and extrahepatic malignancies. J Clin Gastroenterol 1997;24:87-89.

Wilson RA. Extrahepatic manifestations of chronic 42.

viral hepatitis. Am J Gastroenterol 1997;92:4-17. Strassburg CP, Manns MP. Autoimmune hepatitis versus viral hepatitis C. Liver 1995;15:225-232. Scheuer PJ, Ashrafzadeh P, Sherlock S, Brown D, Dusheiko GM. The pathology of hepatitis C. hepa- 43. tology 1992;15:567-571.

Alberti A, Morsica G, Chemello L, et al. Hepatitis C viremia and liver disease in symptom free individuals with anti-HCV. Lancet 1992;340:677-698. 44. Alter HJ. To C or not to C: These are the questions. Blood 1995;85:1681-1695. Koziel MJ. Immunology of viral hepatitis. Am J Med 1996;100:98-109.

Sansonno D, Cornacchiulo V, Iacobelli AR, Di Ste- 45. fano R, Lospalluti M, Dammacco F. Localiztion of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. Hepatology 1995;21:305-312.

Sinico RA, Winearls CG, Sabadini E, Fornasieri A, Catiglione A, D'Amico. Identification of glomerular immune deposits in cryoglobulinemic glomerulonephritis. Kidney Int 1988;34:109-116. Szymanski IO, Pullman JM, Underwood JM. Electron microscopic and immunochemical studies in a patient with hepatitis C virus infection and mixed cryoglobulinemia type II. Am J Clin Pathol 1994;102:278-283.

Rice CM, Walker CM. Hepatitis C virus-specific T lymphocyte responses. Curr Opinion Immunol 1995;7:532-538.

Koziel MJ, Dudley D, Afdhal N, et al. Hepatitis C virus (HCV) specific cytotoxic T lymphocytes recognize epitopes in the core and envelop proteins of HCV. J Virol 1993;67:7522-7532. Cerny A, McHutchison JG, Pasquinelli C, et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995;95:521-530. Chu CM, Liaw YF. Coexpression of intercellular adhesion molecule-I and class I major histocompat-ibilty complex antigens on hepatocyte membrane in chronic viral hepatitis. J Clin Pathol 1993;46:1004-1008.

Mosnier JF, Scoazec JY, Marcellin, Degott C, Ben-hamou JP, Feldmann G. Expression of cytokine-dependent immune adhesion molecules by hepato-cytes and bile duct cells in chronic hepatitis C. Gastroenterology 1994; 107:1457-1468. Liaw YF, Lee CS, Tsai SL, et al. T-cell mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995;22:1368-1373.

Garyfallos A, Raptopoulou-Gigi M, Orphanou H, Spaia S, Petridou P, Vayionas G. Interleukin 2-dependent immunoregulatory function in hemodialysis patients with chronic hepatitis C. J Investig Allergol Clin Immunol 1995;5:255-258. Fukuda R, Satoh S, Nguyen XT, et al. Expression rate of cytokine mRNA in the liver of chronic hepatitis C: Comparison with hepatitis B. J Gastroenterol 1995;30:41-47.

Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM.l. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre-and posttreat-ment with interferon alpha. Hepatology 1996;24:6-9.

Jirillo E, Greco B, Caradonna L, et al. Evaluation of cellular immune responses and soluble mediators in patients with chronic hepatitis C virus infection. Im-munopharmacol Immunotoxicol 1995;17:347-364.

Czaja AJ. Autoimmune hepatitis, evolving concepts and treatment strategies. Dig Dis Sei 1995;40:435-456.

Pawlotsky JM, Roudot-Thoraval F, Simmonds P, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122:169- 173. Richardet JP, Lons T, Johanet C, et al. Prevalence and characteristics of anti-tissue antibodies in chronic hepatitis caused by hepatitis C virus (French). Gastroenterol Clin Biol 1994;18:819-823. Prieto J, Yuste JR, Beloqui O, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the an. Hepatology 1996;23:199-204.

Tran A, Quaranta JF, Benzaken S, et al. High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology 1993;18:253-257. Buskila D, Schnaider A, Neumann L, et al. Musku-loskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998;28:1-8. McMurray RW, Elbourne K. Hepatitis C virus infection and autoimmunity. Semin Arthritis Rheum 1997;26:689-701.

Hartmann H, Schott P, Polzien F, et al. Cryoglobulinemia in chronic hepatitis C virus infection: prevalence, clinical manifestations, response to interferon treatment and analysis of cryoprecipitates. Z Gastroenterol, 1955;33:643-50. Karlsberg PL, Lee WM, Casey DL. Coc CJ, Cruz PD Jr. Cutavasculitis and rheumatoid factor positivity as presenting signs of hepatitis C virus induced mixed cryoglobulinemia. Arch Dermatol 1995; 131:11191123.

Dupin N, Chosidow O, Lunel F, et al. Essential mixed cryoglobulinemia: a comparative study of dermatologic manifestations in patients infected or noninfected with hepatitis C virus. Arch Dermatol 1995;131:1124-1127.

Daoud MS, Gibson LE, Daoud S, el-Azhary RA. Chronic hepatitis C and skin diseases: a review. Mayo Clinic Proc 1995;70:559-564. Johnson RJ, Willson R, Yamabe H. et al. Renal manifestations of hepatitis C virus infection. Kidney Int 1994;46:1255-1263.

Johnson RJ, Gretch DR, Couser WG, et al. Hepatitis C virus-associated glomerulonephritis. Effect of a interferon. Kidney Int 1994;46:1700-1704. Khella SL, Frost S, Hermann GA, et al. Hepatitis C infection, cryoglobulinemia, and vasculitic neuropathy. Treatment with interferon alpha: case report and literature review. Neurology 1995;45:407^111.

60. Stehaman-Breen C, Willson R, Alpers CE, Gretch D, Johnson RJ. Hepatitis C associated glomerulonephritis. Curr Opin Nephrol Hypertens 1995;4:287-294.

61. Weiner SM, Berg T, Berthold H et al. A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J Hepatol 1998;29:375-384.

62. Uneo Y, Kinoshita R, Kishimoto I, Okamoto M. Polyarthritis associated with hepatitis C virus infection. Br J Rheumatol 1994;33:289-291.

63. Uneo Y, Kinoshita R, Tsujinoue H, Kato M. A case of hepatitis C virus (HCV)-associated arthritis. Quantitative analysis of HCV RNA of the synovial fluid and the serum. Br J Rheumatol 1995;34:691-692. ■

64. Ueno Y, Kondo K, Kidokoro N, Kobashi R, Kanaji K, Matsumura T. Hepatitis C infection and polymyositis. Lancet 1995;346:319-320.

65. Bon E, Cantagrel A, Moulinier L, et al. Rheumatic manifestations of chronic hepatitis C and response to the treatment with interferon alpha 2b (French). Rev Rheum Ed Fr 1994;61:497-504.

66. Kimura Y Kajiyama K Nomura H. Severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C associated with systemic lupus erythematosus (Japanese). Fukuoka Igaku Zasshi-Fukuoka Acta Medica 1004;85:329-323.

67. Marchesoni A, Buttafarano N, Podico M. Tosi S. Hepatitis C virus antibodies and systemic lupus erythematosus. Clin Exp Rheumatol 1995; 13:267268.

68. Abu-Shakra M, El-Sana S, Margalith M, Sikuler E, Neumann L, Buskila D. Hepatitis B and C viruses serology in patients with SLE. Lupus 1997;6:543-544.

69. Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW. Polymyosistis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 1995;38:437^139.

70. Nishikai M, Miyairi M, Kosaka S. Dermatomyositis following infection with hepatitis C virus. J Rheumatol 1994;21:1584-1585.

71. Horsmans Y, Geubel AP. Symptomatic myopathy in hepatitis C infection without interferon therapy. Lancet 1995;345:1236.

72. Gorevic PD, Kassab HJ, Levo Y, et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980;69:287-308.

73. Pawlotsky JM, Ben Yahia M, Andre C, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994;19:841-848.

74. Wattiaux MJ, Jouan-Flahault C, Youinou P, et al. Association of Gougerot-Sjögren syndrome and viral hepatitis C: apropos of 6 cases (French). Annal Med Intern 1995;146:247-250.

Marrone A, DiBisceglie AM, Fox P. Absence of hepatitis C viral infection among patients with primary Sjogren's syndrome. J Hepatol 1995;22:599. King PD, McMurray RW, Becherer PR. Sjogren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J gastroenterol 1994;89:1047-1050. Quint L, Deny P, Guillevin L, et al. Hepatitis C virus in patients with polyarteritis nodosa. Prevalence in 38 patients. Clin Exp Rheumatol 1991;9:253-257. Cacoub P, Lunel-Fabiani F, Du LT. Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992;116:605-606.

Hearth-Holmes M, Zahradka SL, Baethga BA, Wolf RE. Leukocytoclastic vasculitis associated with hepatitis C. Am J Med 1991;90:765-766. Durand JM, Kaplanski G, Richard MA, et al. Cutaneous vasculitis in a patient infected with hepatitis C virus. Detection of hepatitis C virus RNA in the skin by polymerase chain reaction. Br J Dermatol 1993;128:359-360.

Marcellin P, Pouteau M, Benhamou JP. Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction. J Hepatol 1995;22:364-369. Roithinger FX, Allinger S, Kirchgatterer A, et al. A lethal course of chronic hepatitis C, glomerulonephritis, and pulmonary vasculitis unresponsive to interferon treatment. Am J Gastroenterol 1995;90:1006-1008.

Gorg S, Niederstadt C, Klouche M, et al. Intestinal vasculitis and glomerulonephritis in hepatitis C-associated cryoglobulinemia. Immunitat und Infektion 1995;23:29-31.

Moder KG, Lindor K. Muskuloskeletal symptoms associated with hepatitis C. Arthritis Rheum 1995;38(suppl):284 (abstr).

Romero Portales M, De Diego Lorenzo A, Rivera J, et al Rheumatologie and autoimmune manifestations in patients with chronic hepatitis C virus infection. Rev Esp Enferm Dig 1997;89:591-598. Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E. Fibromyalgia in hepatitis C virus infection: Another infectious disease relationship. Arch Intra Med 1997;157:2497-2500. Tran A, Quaranta JF, Beusnel C, et al: Hepatitis C virus and Hashimoto thyroiditis. Eur J Med 1992;1:116-118.

Kawaguchi K, Okuwaki J, Takami S. A case of HCV-RNA positive liver cirrhosis with hypergammaglobulinemia and high titers of ANA, accompanied by hypothyroidism (Japanese). Jpn J Gastroenterol 1995;92:909-913.

89. Abuaf N, Lunel F, Giral P, et al. Non-organ specific autoantibodies associated with chronic C virus hepatitis. J Hepatol 1993;18:359-364.

90. Quaranta JF, Tran A, Regnier D, et al. High prevalence of antibodies to hepatitis C virus in patients with anti-thyroid autoantibodis. J Hepatol 1993;18:136-138.

91. Tran A, Benzaken S, Braun HB, et al. Anti-GOR and anti thyroid autoantibodies in patients with chronic hepatitis C. Clin Immunol Immunopathol 1995;77:127-130.

92. Paggi A, Leri O, Taliani G, et al. Hepatitis C virus and autoimmune thyroid diseases, Possible non co-incidential association. Eur J Int Med 1995;6:33-36.

93. Preziati D, LaRosa L, Covini G, et al. Autoimmunity and thyroid function in patients with chronic active hepatitis treated with recombinant interferon-alpha 2a. Eur J Endocrinol 1995;132:587-593.

94. Nagayama Y, Ohta K, Tsuruta M, et al: Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatistis:our studies and review of the literature. Endocrinol J 1994;41:565-572.

95. Rollino C, Roccatello D, Giachino O, Basolo B, Piccoli G. Hepatitis C virus infection and membranous glomerulonephritis. Nephron 1991 ;59:319— 320.

96. Yamabe H, Johnson RJ, Gretch DR. et al. Hepatitis C rirus infection membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 1995;6:220-223.

97. Johnson RJ, GDR, Yamabe H, et al. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993;328:465-470.

98. Sansonno D, Gesualdo L, Manno C, Schena FP, Dammacco F. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis. Hepatology 1997;25:1237— 1244.

99. Lacaille F, Zylberberg H, Hagege H, Roualdes B, Meyrignac C, Chousterman M, Girot R. Hepatitis C associated with Guillain-Barre syndrome. Liver 1998;18:49-51.

100. Colombo M. Hepatocellular carcinoma. J Hepatol 1992;15:225-236.

101. Ferri C, Caracciolo F, Zignego Al et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-394.

102. Isselbacher KJ, Dienstag JL. Tumors of the liver and biliary tract. In: Fauci AS, Braunwald E, Isselbacher KJ et al, eds., Harrison's principles of

Internal Medicine. New York: McGraw-Hill 14th edn 1998:579.

103. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C. A prospective study of 251 patients. Hepatology 1995;21:650-655.

104. Serfaty L, Aumaitre H, Chazouilleres O, Bonnand AM, Rosmorduc O, Rpupon R and Rpupon R. Determinants of outcome of compensated hepatitis C virus-related cirrhosis. Hepatology 1998;27:1435-1440.

105. Fattovich G, giustina G, Degos F, et al. Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients. Gastroenterology 1997; 112:463^172.

106. Ferri C, Caracciolo F, Zignego AL et al. Hepatitis C virus infection in patients with non Hodgkin's lymphoma. Brit J Clin Invest. 1995;25:833-837.

107. Izumi T, Sasaki R, Tsunoda S, Akutsu M, Okamoto H, Minura Y B cell Malignancy and hepatitis C virus infection. Leukemia 1997;(suppl 3):516—518.

108. Silvestri F, Barillari G, Fanin R, et al. The genotype of the hepatitis C virus in patients with HCV-related B cell non-Hodgkin's lymphoma. Leukemia 1997;11:2157-2161.

109. Naschitz JE, Zuckerman E, Elias N, Yeshurun D. Primary hepatosplenic lymphoma of the B-cell variety in a patient with hepatitis C liver cirrhosis. Am J Gastroenterol 1994;89:1915-1916.

110. Ellenrieder V, Beckh K, Muller D, Klatt S, Adler G. Intrahepatic high-grade malignant non-Hodgkin lymphoma in a patient with chronic hepatitis C infection. Z Gastroenterol 1996;34:283-285.

111. Satoh T, Yamada T, Nakano S, et al. The relationship between primary splenic malignant lymphoma and chronic liver disease associated with hepatitis c virus. Cancer 1997;80:1981-1988.

112. Gil J, Rodríguez C, del Toro J, Montenegro T, Fernández-Cruz E, Menárguez J. Fulminant hepatosplenic B cell lymphoma in a young patient with HCV-chronic hepatitis. Leukemia 1998; 12:10051006

113. Perl A, Gorevic PD, Ryan DH, Condemi JJ, Ruszkowski RJ, Abraham GN. Clonal B cell expansion in patients with essential mixed cryoglobulinemia. Clin Exp Immunol 1989;76:54-60.

114. Monteverde A, Rivano MT, Allegra GC, et al. Essential mixed cryoglobulinemia type II: A manifestation of 12 cases with special reference to immuno-histochemical findings. Acta Haemtol 1988;79:20-25.

115. Invernizzi F, Pioltelli P, Cattaneo R, Gavazzeni V, Borzini P, Monti G, Zanussi C. A long-term follow-

up study in essential mixed cryoglobulinemia. Acta Haematol 1979;61:93-99.

116. Mussini C, Ghini M, Zanni G, Campioli D, Bianconi G, Artusi T. Cryoglobulinemia: Bone marrow histological investigation. Con Tissue Res 1992; 11:25.

117. Mussini C, Mascia MT, Zanni G, Curci G. A cy-tomorphological and immunohistochemical study of bone marrow in the diagnosis of essential mixed type II cryoglobulinemia. Haematologica 1991 ;76:389— 391.

118. De Vita S, Sanaonno D, Dolcetti R, et al. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Blood 1995;86:1887-1892.

119. Franzin F, Efremov DG, Pozzato G et al. Clonal B-cell expansions in peripheral blood of HCV-infected patients. Br J Hematol 1995;90:548-552.

120. De Vita S, Sacco C Sanaonno D, et al. Characterization of overt B-cell lymphomas in patients with Hepatitis C virus infection. Blood 1997;90:776-782.

121. Ascoli V, Coco FL Artini M, Levrero M, Martelli M, Negro F. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 1998;109:600-609.

122. Lai R, Weiss LM. Hepatitis C virus and Non-Hodgkin's lynphoma. Am J Clin Pathol 1998;109:508-510.

123. La Civita L, Zignego AL, Monti M, Longombardo G, Greco F, Pasero G, Ferri C. Type C hepatitis and chronic lymphocytic leukemia (letter). Eur J cancer 1996;32A: 1819-1820.

124. Marinella MA, Moseley RH. Chronic lymphocytic leukemia complicating chronic hepatitis C infection. J Clin Gastroenterol 1996;23:302.

125. Porter SR, Lodi G, Chandler K, Kumar N. De-velopmant of squamous cell carcinoma in hepatitis C virus-associated lichen planus. Oral Oncol 1997;33:58-59.

126. Carrozzo M, Carbone M, Gandolfo S, Valente G, Colombatto P, Ghisetti V. An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Oral Oncol 1997;33:220-225.

127. El-Refaie A, Savage K, Bhattacharya S et al. HCV-associated hepatocellular carcinoma without cirrhosis. J hepatol 1996;24:277-285.

128. Kasahara A, Hayashi N, Mochizuki K, Takayanagi M, Yoshioka K, Kakumu S, Iijima A et al. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chrinic hepatitis C. Hepatology 1998;27:1394-1402.

129. De-Mitri MS, Poussin K, Baccarini P Pontisso P, D'Errico A, Simon N, Grigioni W, Alberti A, Beau-grand M, Pisi E, Christian Brechot, Paterlini P. HCV

associated liver cancer without cirrhosis. Lancet 1995;345:413-415.

130. Morris JD, Eddleston AL, Crook T. Viral infection and Cancer. Lancet 1995;346:754-758.

131. Gorevic PD, Frangione B. Mixed cryoglobulinemia cross- reactive idiotypes: implication for relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991;28:79-94.

132. Ferri C, Monti M, La Civita L et al. Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinemia. Euro. J. Clin. Inves. 1994;24:781-784.

133. Mishiro S, Takeda K, Hoshi Y, Yoshikawa A, Gotanda T, Itoh Y. An auto-antibody cross-reactive to hepatitis C-virus core and a host nuclear antigen. Autoimmunity 1991;10:269-273.

134. Ellis M, Rathaus M, Amiel A, Manor Y, Klein A, Lishner M. Monoclonal lymphocytic proliferation and bcl-2 rearrangement in essential mixed cryoglobulinemia. Europ. J. Clin. Invest 1995;25:833-837.

135. Lau JYN, Xie X, Lai MMC, WU PC. Apopto-sis and viral hepatitis. Seminars in liver disease 1998;18:169-176.

136. Zignego AL, Giannelli F, Giannini C et al. Bcl-2 rearrangement in mixed cryoglobulinemia and HCV-related chronic disease. Abstracts of the International Meeting of hepatitis C virus and related viruses. Molecular virology and pathogenesis, Venezia, June 1998:169.

137. Ishido S, Fujita T, Hotta H. Complex formation of hepatitis C virus NS3 protein with the P53 tumor suppressor protein. Abstracts of the International Meeting of hepatitis C virus and related viruses. Molecular virology and pathogenesis, Venezia 1998:090

138. Chen SY, Kao CF, Chen JY, Lee YHWL. Direct association of the hepatitis C virus core protein with tumor suppressor P53 modulates the transcriptional activity of P53. Abstracts of the International Meeting of hepatitis C virus and related viruses. Molecular virology and pathogenesis, Venezia 1998:104.

© 2000 Elsevier Science B.V. All rights reserved. Cancer and Autoimmunity Y. Shoenfeld and M. E. Gershwin, editors

Was this article helpful?

0 0
Arthritis Relief Now

Arthritis Relief Now

When you hear the word arthritis, images of painful hands and joints comes into play. Few people fully understand arthritis and this guide is dedicated to anyone suffering with this chronic condition and wants relief now.

Get My Free Ebook


Post a comment